A New Selective Peroxisome Proliferator-Activated Receptor γ Antagonist with Antiobesity and Antidiabetic Activity
Jennifer Rieusset, Fethi Touri, Liliane Michalik et al. · Molecular Endocrinology · 2002
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) plays a key role in adipocyte differentiation and insulin sensitivity. Its synthetic ligands, the thiazolidinediones (TZD), are used as insulin sensitizers in the treatment of type 2 diabetes. These compounds induce both adipocyte differentiation in cell culture models and promote weight gain in rodents and humans. Here, we report on the identification of a new synthetic PPARgamma antagonist, the phosphonophosphate SR-202, which inhibits both TZD-stimulated recruitment of the coactivator steroid receptor coactivator-1 and TZD-induced transcriptional activity of the receptor. In cell culture, SR-202 efficiently antagonizes hormone- and TZD-induced adipocyte differentiation. In vivo, decreasing PPARgamma activity, either by treatment with SR-202 or by invalidation of one allele of the PPARgamma gene, leads to a reduction of both high fat diet-induced adipocyte hypertrophy and insulin resistance. These effects are accompanied by a smaller size of the adipocytes and a reduction of TNFalpha and leptin secretion. Treatment with SR-202 also dramatically improves insulin sensitivity in the diabetic ob/ob mice. Thus, although we cannot exclude that its actions involve additional signaling mechanisms, SR-202 represents a new selective PPARgamma antagonist that is effective both in vitro and in vivo. Because it yields both antiobesity and antidiabetic effects, SR-202 may be a lead for new compounds to be used in the treatment of obesity and type 2 diabetes.
Cited by 214 works. doi:10.1210/me.2002-0036 Open-access PDF
Authors
- Jennifer Rieusset
- Fethi Touri
- Liliane Michalik
- Pascal Escher
- Béatrice Desvergne
- Eric J. Niesor
- Walter Wahli
References
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
- PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
- PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism